Kunishima Shinji, Kobayashi Ryoji, Itoh Tomohiko J, Hamaguchi Motohiro, Saito Hidehiko
Department of Hemostasis and Thrombosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Blood. 2009 Jan 8;113(2):458-61. doi: 10.1182/blood-2008-06-162610. Epub 2008 Oct 10.
Congenital macrothrombocytopenia is a genetically heterogeneous group of rare disorders. We identified the first TUBB1 mutation, R318W, in a patient with congenital macrothrombocytopenia. The patient was heterozygous for Q43P, but this single-nucleotide polymorphism (SNP) did not relate to macrothrombocytopenia. Although no abnormal platelet beta1-tubulin localization/marginal band organization was observed, the level of beta1-tubulin was decreased by approximately 50% compared with healthy controls. Large and irregular bleb protrusions observed in megakaryocytes derived from the patient's peripheral blood CD34(+) cells suggested impaired megakaryocyte fragmentation and release of large platelets. In vitro transfection experiments in Chinese hamster ovary (CHO) cells demonstrated no incorporation of mutant beta1-tubulin into microtubules, but the formation of punctuated insoluble aggregates. These results suggested that mutant protein is prone to aggregation but is unstable within megakaryocytes/platelets. Alternatively, mutant beta1-tubulin may not be transported from the megakaryocytes into platelets. W318 beta1-tubulin may interfere with normal platelet production, resulting in macrothrombocytopenia.
先天性巨血小板减少症是一组具有遗传异质性的罕见疾病。我们在一名先天性巨血小板减少症患者中鉴定出首个TUBB1突变,即R318W。该患者为Q43P杂合子,但这种单核苷酸多态性(SNP)与巨血小板减少症无关。尽管未观察到血小板β1-微管蛋白定位/边缘带组织异常,但与健康对照相比,β1-微管蛋白水平降低了约50%。在源自患者外周血CD34(+)细胞的巨核细胞中观察到的大而不规则的泡状突起表明巨核细胞碎裂受损以及大血小板释放。在中国仓鼠卵巢(CHO)细胞中进行的体外转染实验表明,突变型β1-微管蛋白未掺入微管中,而是形成了点状不溶性聚集体。这些结果表明,突变蛋白易于聚集,但在巨核细胞/血小板内不稳定。或者,突变型β1-微管蛋白可能无法从巨核细胞转运到血小板中。W318β1-微管蛋白可能会干扰正常血小板生成,导致巨血小板减少症。